NCT01143298View on ClinicalTrials.gov

LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

September 30, 2010

Conditions

Healthy

Interventions

DRUG

LEO 27847 oral solution

Trial Locations (1)

Unknown

Covance Clinical Research Unit Ltd., Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY